The NP-AFP rate for 2022 has improved significantly to 4.8/100,000 compared with 3.8/100,000 in 2021, an improvement of 26.3%, which shows the surveillance became more sensitive and would not miss any polio outbreaks in the region. The gene discussed is AFP; the disease is poliomyelitis.